Viewing Study NCT02408861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:30 PM
Ignite Modification Date: 2026-05-17 @ 4:40 AM
Study NCT ID: NCT02408861
Status: TERMINATED
Last Update Posted: 2025-09-23
First Post: 2015-04-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Solid Neoplasm View
None Anal Carcinoma View
None HIV Infection View
None Kaposi Sarcoma View
None Lung Carcinoma View
None Metastatic Malignant Solid Neoplasm View
None Recurrent Classic Hodgkin Lymphoma View
None Refractory Classic Hodgkin Lymphoma View
None Unresectable Solid Neoplasm View
None HIV-associated Cancers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Immune check point blockade View
None Anti-CTLA-4 antibody View
None Anti-PD1 antibody View
None Phase 1 View
None Dose de-escalation View
None Dose expansion View